An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals like DNA for reliably storing massive amounts of data. . . . → Read More: Synthetic DNA Studied for Mass Data Storage
|
|||||
|
|
Engineers developed a more sustainable type of concrete adding a form of bacteria to grow and reproduce the material under most conditions. . . . → Read More: Living, Reproducing Concrete Created with Bacteria 
A chip device simulating intestinal functions, bolstered by a gut tissue organoid, behaves more like a human intestine in lab tests than the gut organoid alone. . . . → Read More: Organoid in Chip Device Better Simulates Gut Functions 
UPMC, the medical center affiliated with University of Pittsburgh, plans to invest $1 billion in life science advances, with spin-off companies as part of its strategy. . . . → Read More: UPMC to Invest $1 Billion in Medical Enterprises 
A team of biologists and computer scientists created tiny robotic devices designed by computer models and made from frog embryo cells. . . . → Read More: Algorithm-Designed Robots Made from Living Cells 
A gene therapy start-up is receiving an award resembling venture financing to advance its treatment for a rare inherited neuromuscular disorder to clinical trials. . . . → Read More: Venture Philanthropy Funds Rare Neuro Disease Trial 
A wireless electrode activated by light waves is being developed to connect with nerve cells in the brain that promises to make brain-computer connections safer. . . . → Read More: Light-Activated Brain Electrodes in Development 
Drug maker Boehringer Ingelheim is acquiring an antibody technology that blocks actions of a signaling protein associated with a range of fibrosis diseases. . . . → Read More: Pharma Gains Fibrosis Technology in $1B+ Deal 
A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round. . . . → Read More: Vaccine Developer Gains $11M in Early Funds 
A joint venture of two drug discovery and design companies aims to create new biotechnology businesses to find drugs for treating rare diseases. . . . → Read More: A.I. Discovery Companies to Find Rare Disease Drugs |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
